Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
ABIRATERONE + Digitoxin
|
DCFRJ3A
|
ABIRATERONE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
ABIRATERONE + Digitoxin
|
DCP1WD6
|
ABIRATERONE
|
Glioma (Cell Line: SF-268)
|
[2] |
ABIRATERONE + Digitoxin
|
DCRG75V
|
ABIRATERONE
|
Renal cell carcinoma (Cell Line: UO-31)
|
[2] |
ABIRATERONE + Digitoxin
|
DC9Z7UN
|
ABIRATERONE
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
ABIRATERONE + Digitoxin
|
DCQBY84
|
ABIRATERONE
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[3] |
ABIRATERONE + Digitoxin
|
DC135N2
|
ABIRATERONE
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[4] |
ABIRATERONE + Digitoxin
|
DCWWV3F
|
ABIRATERONE
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[4] |
ABIRATERONE + Digitoxin
|
DC5OZXB
|
ABIRATERONE
|
Melanoma (Cell Line: UACC-257)
|
[4] |
ABIRATERONE + Digitoxin
|
DC4C1TV
|
ABIRATERONE
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
Amonafide + Digitoxin
|
DCZC6HY
|
Amonafide
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
Amonafide + Digitoxin
|
DC84S2B
|
Amonafide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Amonafide + Digitoxin
|
DC4QVPI
|
Amonafide
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Amonafide + Digitoxin
|
DCKB09K
|
Amonafide
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Amonafide + Digitoxin
|
DC2BSCR
|
Amonafide
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
Amonafide + Digitoxin
|
DCBCDZZ
|
Amonafide
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
Amonafide + Digitoxin
|
DCZJNIA
|
Amonafide
|
Glioma (Cell Line: SF-539)
|
[2] |
Amonafide + Digitoxin
|
DCTD209
|
Amonafide
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Anastrozole + Digitoxin
|
DCYH82Y
|
Anastrozole
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
Anastrozole + Digitoxin
|
DCZ76CW
|
Anastrozole
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[2] |
Anastrozole + Digitoxin
|
DC1OGW8
|
Anastrozole
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
Anastrozole + Digitoxin
|
DCZ2SH5
|
Anastrozole
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Anastrozole + Digitoxin
|
DCBLDDE
|
Anastrozole
|
Glioma (Cell Line: SF-268)
|
[2] |
Anastrozole + Digitoxin
|
DC2WRDX
|
Anastrozole
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Anastrozole + Digitoxin
|
DC3K4Y3
|
Anastrozole
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[2] |
Anastrozole + Digitoxin
|
DCHK22O
|
Anastrozole
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Anastrozole + Digitoxin
|
DCNMBQF
|
Anastrozole
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[2] |
Anastrozole + Digitoxin
|
DCEOTIC
|
Anastrozole
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Arfolitixorin + Digitoxin
|
DC9JCO0
|
Arfolitixorin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
BIO-300 + Digitoxin
|
DCQ6HWG
|
BIO-300
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
BIO-300 + Digitoxin
|
DCH70R2
|
BIO-300
|
Glioma (Cell Line: SF-539)
|
[2] |
BIO-300 + Digitoxin
|
DCN15US
|
BIO-300
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[4] |
Bleomycin + Digitoxin
|
DCDTT5R
|
Bleomycin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Bleomycin + Digitoxin
|
DCENO7E
|
Bleomycin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Bleomycin + Digitoxin
|
DC6805C
|
Bleomycin
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
Bleomycin + Digitoxin
|
DC43BFF
|
Bleomycin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Bleomycin + Digitoxin
|
DCCPUPT
|
Bleomycin
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
Bleomycin + Digitoxin
|
DC2ESS0
|
Bleomycin
|
Glioma (Cell Line: SF-539)
|
[2] |
Bleomycin + Digitoxin
|
DCON03K
|
Bleomycin
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[4] |
Bleomycin + Digitoxin
|
DCP30WW
|
Bleomycin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
Cabazitaxel + Digitoxin
|
DC72SEL
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
Cabazitaxel + Digitoxin
|
DCAZH9E
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
Cabazitaxel + Digitoxin
|
DCE1VZ5
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[2] |
Cabazitaxel + Digitoxin
|
DCOZX4K
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: HCT-15)
|
[2] |
Cabazitaxel + Digitoxin
|
DCTQ49D
|
Cabazitaxel
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Cabazitaxel + Digitoxin
|
DCXBWY7
|
Cabazitaxel
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Cabazitaxel + Digitoxin
|
DCG3EXU
|
Cabazitaxel
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Cabazitaxel + Digitoxin
|
DC22EZS
|
Cabazitaxel
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
Cabazitaxel + Digitoxin
|
DCFLU7A
|
Cabazitaxel
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
Cabazitaxel + Digitoxin
|
DCB425F
|
Cabazitaxel
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[2] |
Cabazitaxel + Digitoxin
|
DCHKX4W
|
Cabazitaxel
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Cabazitaxel + Digitoxin
|
DC2R6KA
|
Cabazitaxel
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Cabazitaxel + Digitoxin
|
DC4NQ9R
|
Cabazitaxel
|
Prostate carcinoma (Cell Line: PC-3)
|
[2] |
Cabazitaxel + Digitoxin
|
DCCI6IA
|
Cabazitaxel
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
Cabazitaxel + Digitoxin
|
DC7SOWI
|
Cabazitaxel
|
Carcinoma (Cell Line: RXF 393)
|
[3] |
Cabazitaxel + Digitoxin
|
DCY7PWB
|
Cabazitaxel
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[3] |
Crizotinib + Digitoxin
|
DC2B108
|
Crizotinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Crizotinib + Digitoxin
|
DCBLO11
|
Crizotinib
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
Crizotinib + Digitoxin
|
DC654JN
|
Crizotinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[2] |
Crizotinib + Digitoxin
|
DC1V09B
|
Crizotinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Crizotinib + Digitoxin
|
DCYAASH
|
Crizotinib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
Dacarbazine + Digitoxin
|
DCUJADG
|
Dacarbazine
|
Glioma (Cell Line: SF-539)
|
[2] |
Dacarbazine + Digitoxin
|
DCWGACP
|
Dacarbazine
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Dactinomycin + Digitoxin
|
DCCEGMP
|
Dactinomycin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[4] |
Dactinomycin + Digitoxin
|
DCVWY0O
|
Dactinomycin
|
Adenocarcinoma (Cell Line: A549)
|
[4] |
Dactinomycin + Digitoxin
|
DCZ9G6M
|
Dactinomycin
|
Adenocarcinoma (Cell Line: HT29)
|
[4] |
Dactinomycin + Digitoxin
|
DCDM34J
|
Dactinomycin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[4] |
Dactinomycin + Digitoxin
|
DCKUHMN
|
Dactinomycin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[4] |
Dactinomycin + Digitoxin
|
DCP3EK2
|
Dactinomycin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[4] |
Dactinomycin + Digitoxin
|
DCJPXFQ
|
Dactinomycin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[4] |
Dactinomycin + Digitoxin
|
DC0TVVX
|
Dactinomycin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
Dexrazoxane + Digitoxin
|
DCORI0M
|
Dexrazoxane
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Dexrazoxane + Digitoxin
|
DCTCA5J
|
Dexrazoxane
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Dexrazoxane + Digitoxin
|
DCV95FC
|
Dexrazoxane
|
Glioma (Cell Line: SF-268)
|
[2] |
Dexrazoxane + Digitoxin
|
DCGQWGD
|
Dexrazoxane
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[4] |
Dexrazoxane + Digitoxin
|
DCAHLF0
|
Dexrazoxane
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[4] |
DFN-15 + Digitoxin
|
DCRH3X1
|
DFN-15
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
Digitoxin + Pentostatin
|
DCAXJJR
|
Pentostatin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[2] |
Digitoxin + Hepzato
|
DCGC62M
|
Hepzato
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
Digitoxin + Ixabepilone
|
DCO5B2W
|
Ixabepilone
|
Adenocarcinoma (Cell Line: HCT-15)
|
[2] |
Digitoxin + Ixabepilone
|
DCFE3OX
|
Ixabepilone
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Dactinomycin
|
DCI9ZII
|
Dactinomycin
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
Digitoxin + Lapatinib
|
DCFXT0Q
|
Lapatinib
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
Digitoxin + Lapatinib
|
DCWPU0E
|
Lapatinib
|
Glioma (Cell Line: SF-295)
|
[2] |
Digitoxin + PMID28460551-Compound-2
|
DCUJMDV
|
PMID28460551-Compound-2
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Digitoxin + PMID28460551-Compound-2
|
DCV4HGW
|
PMID28460551-Compound-2
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Digitoxin + PMID28460551-Compound-2
|
DCIY727
|
PMID28460551-Compound-2
|
Renal cell carcinoma (Cell Line: UO-31)
|
[2] |
Digitoxin + Cyclophosphamide
|
DCZAXNO
|
Cyclophosphamide
|
Glioma (Cell Line: SF-539)
|
[2] |
Digitoxin + Arsenic trioxide
|
DC9OU63
|
Arsenic trioxide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Arsenic trioxide
|
DC039Q7
|
Arsenic trioxide
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
Digitoxin + Arsenic trioxide
|
DCUKX5B
|
Arsenic trioxide
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Digitoxin + Arsenic trioxide
|
DCEN60M
|
Arsenic trioxide
|
Melanoma (Cell Line: UACC-257)
|
[2] |
Digitoxin + Plicamycin
|
DCU4HRG
|
Plicamycin
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[2] |
Digitoxin + Nilotinib
|
DC0IAFY
|
Nilotinib
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[2] |
Digitoxin + Nilotinib
|
DCGK14D
|
Nilotinib
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
Digitoxin + Nilotinib
|
DCXZBKJ
|
Nilotinib
|
Amelanotic melanoma (Cell Line: M14)
|
[2] |
Digitoxin + Nilotinib
|
DCH1MIJ
|
Nilotinib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[2] |
Digitoxin + Nilotinib
|
DCG3UCK
|
Nilotinib
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Digitoxin + Nilotinib
|
DC0ZW8S
|
Nilotinib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Digitoxin + Nilotinib
|
DCOW5N4
|
Nilotinib
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[2] |
Digitoxin + Triapine
|
DCYRXOV
|
Triapine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + 10-hydroxycamptothecin
|
DCOR1GR
|
10-hydroxycamptothecin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + SCH 727965
|
DC4QCRS
|
SCH 727965
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Digitoxin + SCH 727965
|
DCQP3OV
|
SCH 727965
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[2] |
Digitoxin + Ifosfamide
|
DCLF1JC
|
Ifosfamide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Ifosfamide
|
DCUD92W
|
Ifosfamide
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Digitoxin + Docetaxel
|
DCV6E2K
|
Docetaxel
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
Digitoxin + Raloxifene
|
DCKEYE4
|
Raloxifene
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Digitoxin + Raloxifene
|
DCTE9U0
|
Raloxifene
|
Amelanotic melanoma (Cell Line: M14)
|
[2] |
Digitoxin + Raloxifene
|
DCHSNID
|
Raloxifene
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Digitoxin + Raloxifene
|
DC7EFJD
|
Raloxifene
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[2] |
Digitoxin + Raloxifene
|
DCE44UW
|
Raloxifene
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Raloxifene
|
DC5NQ7L
|
Raloxifene
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + Raloxifene
|
DCLFBX1
|
Raloxifene
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[2] |
Digitoxin + Sirolimus
|
DC7SLLH
|
Sirolimus
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Digitoxin + Mitomycin
|
DCNURVI
|
Mitomycin
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
Digitoxin + Mitomycin
|
DC36ZPL
|
Mitomycin
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
Digitoxin + Mitomycin
|
DCLKPHW
|
Mitomycin
|
Adenocarcinoma (Cell Line: HCT-15)
|
[2] |
Digitoxin + Mitomycin
|
DCDXBBU
|
Mitomycin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Mitomycin
|
DC5OIND
|
Mitomycin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Mitomycin
|
DCS4N8D
|
Mitomycin
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
Digitoxin + Mitomycin
|
DCQEHHH
|
Mitomycin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Digitoxin + Mitomycin
|
DCVVOYG
|
Mitomycin
|
Glioma (Cell Line: SF-539)
|
[2] |
Digitoxin + Mitomycin
|
DCM3OWN
|
Mitomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Mitomycin
|
DCNWFNJ
|
Mitomycin
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + SY-1425
|
DCLQ4Z1
|
SY-1425
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + Idarubicin
|
DCZXXQ2
|
Idarubicin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[2] |
Digitoxin + Imatinib
|
DCLZ4B7
|
Imatinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Bleomycin
|
DCY0XD6
|
Bleomycin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Bleomycin
|
DCD2RNH
|
Bleomycin
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
Digitoxin + Bleomycin
|
DCBOT5L
|
Bleomycin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Digitoxin + Bleomycin
|
DC0EN6J
|
Bleomycin
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[2] |
Digitoxin + Bortezomib
|
DC17VAK
|
Bortezomib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Bortezomib
|
DCZGZTM
|
Bortezomib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Bortezomib
|
DC0LKUV
|
Bortezomib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[2] |
Digitoxin + Valrubicin
|
DCRBCI4
|
Valrubicin
|
Amelanotic melanoma (Cell Line: M14)
|
[2] |
Digitoxin + Valrubicin
|
DCP8YL9
|
Valrubicin
|
Glioma (Cell Line: SF-295)
|
[2] |
Digitoxin + Valrubicin
|
DC9HF1Z
|
Valrubicin
|
Glioma (Cell Line: SF-268)
|
[2] |
Digitoxin + Valrubicin
|
DCT3VKB
|
Valrubicin
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[2] |
Digitoxin + Cisplatin
|
DCRA1IM
|
Cisplatin
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
Digitoxin + Cisplatin
|
DCY0CSD
|
Cisplatin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Digitoxin + Cisplatin
|
DC8CTGO
|
Cisplatin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Cisplatin
|
DCQM69E
|
Cisplatin
|
Astrocytoma (Cell Line: U251)
|
[2] |
Digitoxin + Cisplatin
|
DCPRJIV
|
Cisplatin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Digitoxin + Cisplatin
|
DCDVGRF
|
Cisplatin
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[2] |
Digitoxin + Cisplatin
|
DC3YJT5
|
Cisplatin
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[2] |
Digitoxin + Cisplatin
|
DCHJ5RQ
|
Cisplatin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[2] |
Digitoxin + Cisplatin
|
DC2Y0J3
|
Cisplatin
|
Melanoma (Cell Line: MALME-3M)
|
[2] |
Digitoxin + Cisplatin
|
DCSVKDC
|
Cisplatin
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Digitoxin + Cisplatin
|
DCXB7SO
|
Cisplatin
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
Digitoxin + Cisplatin
|
DCX7KLZ
|
Cisplatin
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
Digitoxin + Sorafenib
|
DCGKJ93
|
Sorafenib
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[2] |
Digitoxin + ER819762
|
DC0F9LB
|
ER819762
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
Digitoxin + ER819762
|
DC9FBZ8
|
ER819762
|
Prostate carcinoma (Cell Line: PC-3)
|
[2] |
Digitoxin + ER819762
|
DCLRNYN
|
ER819762
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
Digitoxin + Romidepsin
|
DCI9LTA
|
Romidepsin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[2] |
Digitoxin + Romidepsin
|
DCHMJNT
|
Romidepsin
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[2] |
Digitoxin + Azacitidine
|
DC225IB
|
Azacitidine
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
Digitoxin + Azacitidine
|
DCSK9VL
|
Azacitidine
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + Pomalidomide
|
DCUVUZD
|
Pomalidomide
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
Digitoxin + Vinflunine
|
DCF8C2P
|
Vinflunine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Vinflunine
|
DCEOJTX
|
Vinflunine
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
Digitoxin + Vinflunine
|
DCMYCWC
|
Vinflunine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[2] |
Digitoxin + Vinflunine
|
DCZQV2C
|
Vinflunine
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + Vinflunine
|
DCZDYKM
|
Vinflunine
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[2] |
Digitoxin + Vinflunine
|
DCYAJUQ
|
Vinflunine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
Digitoxin + Mercaptopurine
|
DCFC1UL
|
Mercaptopurine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[2] |
Digitoxin + Taxol
|
DC67E0P
|
Taxol
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
Digitoxin + Taxol
|
DCC486V
|
Taxol
|
Glioma (Cell Line: SF-295)
|
[2] |
Digitoxin + Taxol
|
DC9R1VC
|
Taxol
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
Digitoxin + PMID28870136-Compound-43
|
DCZS8UG
|
PMID28870136-Compound-43
|
Glioma (Cell Line: SF-295)
|
[2] |
Digitoxin + FORMESTANE
|
DC1LW86
|
FORMESTANE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC6TW8M
|
Aminolevulinic Acid Hydrochloride
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DCT500K
|
Aminolevulinic Acid Hydrochloride
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC2VQ89
|
Aminolevulinic Acid Hydrochloride
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC8363F
|
Aminolevulinic Acid Hydrochloride
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[2] |
Digitoxin + Estramustine
|
DCGFAYN
|
Estramustine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Digitoxin + Estramustine
|
DCPHULZ
|
Estramustine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Digitoxin + Estramustine
|
DC1ESK3
|
Estramustine
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
Digitoxin + Estramustine
|
DCCHLJZ
|
Estramustine
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[2] |
Digitoxin + Busulfan
|
DCBF0YK
|
Busulfan
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
Digitoxin + Dasatinib
|
DC34BJ9
|
Dasatinib
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[2] |
Digitoxin + Dasatinib
|
DCF1HQ7
|
Dasatinib
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Digitoxin + Cyclophosphamide
|
DCRIRDJ
|
Cyclophosphamide
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Digitoxin + Plicamycin
|
DCPNQ3X
|
Plicamycin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Digitoxin + Nilotinib
|
DCWOHN2
|
Nilotinib
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Digitoxin + Mitomycin
|
DCKA68P
|
Mitomycin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Digitoxin + Mitomycin
|
DCZTPVR
|
Mitomycin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Digitoxin + Imatinib
|
DC9FNOX
|
Imatinib
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Digitoxin + Sorafenib
|
DCZ9HN6
|
Sorafenib
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Digitoxin + Vinflunine
|
DCNC5Z0
|
Vinflunine
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Digitoxin + Vinflunine
|
DCDW38J
|
Vinflunine
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[3] |
Digitoxin + Taxol
|
DC3OA1H
|
Taxol
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[3] |
Digitoxin + FORMESTANE
|
DCK2JKL
|
FORMESTANE
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Digitoxin + FORMESTANE
|
DCFFF9X
|
FORMESTANE
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DCW291W
|
Aminolevulinic Acid Hydrochloride
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Digitoxin + Estramustine
|
DCVSXTY
|
Estramustine
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Epirubicin + Digitoxin
|
DCHBOX4
|
Epirubicin
|
Renal cell carcinoma (Cell Line: UO-31)
|
[2] |
Epirubicin + Digitoxin
|
DCXVUKE
|
Epirubicin
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Epirubicin + Digitoxin
|
DCSZ9UG
|
Epirubicin
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[3] |
Epirubicin + Digitoxin
|
DCOLIIW
|
Epirubicin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[4] |
Epirubicin + Digitoxin
|
DCGHYLG
|
Epirubicin
|
Melanoma (Cell Line: UACC-257)
|
[4] |
Epirubicin + Digitoxin
|
DCFZDTX
|
Epirubicin
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[4] |
Fludarabine + Digitoxin
|
DCR46XO
|
Fludarabine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Fludarabine + Digitoxin
|
DCK2NC0
|
Fludarabine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Fludarabine + Digitoxin
|
DC7OGH1
|
Fludarabine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[4] |
Fludarabine + Digitoxin
|
DCW6HZB
|
Fludarabine
|
Malignant melanoma (Cell Line: UACC62)
|
[4] |
Gefitinib + Digitoxin
|
DCQ4BWQ
|
Gefitinib
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
Gefitinib + Digitoxin
|
DCNN93R
|
Gefitinib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
Gefitinib + Digitoxin
|
DCIGSTW
|
Gefitinib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[2] |
Gefitinib + Digitoxin
|
DC9AVZT
|
Gefitinib
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
Gefitinib + Digitoxin
|
DCUV21H
|
Gefitinib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
Gefitinib + Digitoxin
|
DCI0YJ1
|
Gefitinib
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
Gefitinib + Digitoxin
|
DCB1JS7
|
Gefitinib
|
Glioma (Cell Line: SF-268)
|
[2] |
Gefitinib + Digitoxin
|
DC53Y8T
|
Gefitinib
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[2] |
Gefitinib + Digitoxin
|
DCHXZL7
|
Gefitinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
Gefitinib + Digitoxin
|
DCX38RK
|
Gefitinib
|
Melanoma (Cell Line: MALME-3M)
|
[2] |
Gefitinib + Digitoxin
|
DCZB1DC
|
Gefitinib
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
Gefitinib + Digitoxin
|
DCHNTDG
|
Gefitinib
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[2] |
Gefitinib + Digitoxin
|
DC642D1
|
Gefitinib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
Gefitinib + Digitoxin
|
DCK35F4
|
Gefitinib
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Indazole derivative 5 + Digitoxin
|
DCM306V
|
Indazole derivative 5
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
Indazole derivative 5 + Digitoxin
|
DC90Z56
|
Indazole derivative 5
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Indazole derivative 5 + Digitoxin
|
DCASYIT
|
Indazole derivative 5
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Indazole derivative 5 + Digitoxin
|
DCG4HOI
|
Indazole derivative 5
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Indazole derivative 5 + Digitoxin
|
DCLPJNS
|
Indazole derivative 5
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[4] |
JNK-IN-8 + Digitoxin
|
DC09BFW
|
JNK-IN-8
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
JNK-IN-8 + Digitoxin
|
DCLES7L
|
JNK-IN-8
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Lenalidomide + Digitoxin
|
DC180UQ
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[4] |
Letrozole + Digitoxin
|
DCFPO5Z
|
Letrozole
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[2] |
LIAROZOLE + Digitoxin
|
DCA0KGO
|
LIAROZOLE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Mechlorethamine + Digitoxin
|
DCNKQ6P
|
Mechlorethamine
|
Colon carcinoma (Cell Line: KM12)
|
[3] |
Mechlorethamine + Digitoxin
|
DCNNYGC
|
Mechlorethamine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Mechlorethamine + Digitoxin
|
DCTZLPY
|
Mechlorethamine
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[4] |
Ruxolitinib + Digitoxin
|
DCMF1XI
|
Ruxolitinib
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Thioguanine + Digitoxin
|
DCJXNV2
|
Thioguanine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Thioguanine + Digitoxin
|
DC1GAOS
|
Thioguanine
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
Thioguanine + Digitoxin
|
DC7Q6R1
|
Thioguanine
|
Glioma (Cell Line: SF-295)
|
[2] |
Thioguanine + Digitoxin
|
DCT7LTX
|
Thioguanine
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[4] |
Topotecan + Digitoxin
|
DCOUW8V
|
Topotecan
|
Carcinoma (Cell Line: MCF7)
|
[3] |
Topotecan + Digitoxin
|
DCSDBKT
|
Topotecan
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[4] |
Topotecan + Digitoxin
|
DC053EN
|
Topotecan
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[4] |
Topotecan + Digitoxin
|
DCDY80T
|
Topotecan
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[4] |
Topotecan + Digitoxin
|
DC12I92
|
Topotecan
|
Glioma (Cell Line: SF-268)
|
[4] |
Topotecan + Digitoxin
|
DC120SR
|
Topotecan
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[4] |
Topotecan + Digitoxin
|
DCS4XV9
|
Topotecan
|
Melanoma (Cell Line: MALME-3M)
|
[4] |
Topotecan + Digitoxin
|
DCGRATT
|
Topotecan
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[4] |
Topotecan + Digitoxin
|
DC1770M
|
Topotecan
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[4] |
Topotecan + Digitoxin
|
DCTUAY5
|
Topotecan
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[4] |
Topotecan + Digitoxin
|
DCUSFKC
|
Topotecan
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[4] |
Topotecan + Digitoxin
|
DCTHN3V
|
Topotecan
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[4] |
Trifluridine + Digitoxin
|
DC99OBA
|
Trifluridine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
Trifluridine + Digitoxin
|
DCLGIQG
|
Trifluridine
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
Trifluridine + Digitoxin
|
DCVX6T8
|
Trifluridine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
Trifluridine + Digitoxin
|
DCUB1XH
|
Trifluridine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[4] |
Vandetanib + Digitoxin
|
DCMNLFS
|
Vandetanib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[4] |
Vandetanib + Digitoxin
|
DCFDU8Z
|
Vandetanib
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[4] |
Vemurafenib + Digitoxin
|
DCJCFJA
|
Vemurafenib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[3] |
Vemurafenib + Digitoxin
|
DC6B93R
|
Vemurafenib
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[4] |
Vemurafenib + Digitoxin
|
DC81K2X
|
Vemurafenib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[4] |
Vemurafenib + Digitoxin
|
DCNSU76
|
Vemurafenib
|
Melanoma (Cell Line: UACC-257)
|
[4] |
Vemurafenib + Digitoxin
|
DCLBAMM
|
Vemurafenib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[4] |
Vincristine + Digitoxin
|
DCEDT1D
|
Vincristine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[3] |
Vismodegib + Digitoxin
|
DCO2RD0
|
Vismodegib
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[3] |
Vismodegib + Digitoxin
|
DCGXIJ6
|
Vismodegib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[4] |
Vismodegib + Digitoxin
|
DCB1RWU
|
Vismodegib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[4] |
Vismodegib + Digitoxin
|
DCFHNRK
|
Vismodegib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[4] |
Vismodegib + Digitoxin
|
DCUHPNB
|
Vismodegib
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[4] |
------------------------------------------------------------------------------------ |
|
|
|
|